A previous study showed that strictinin treatment modulated the PI3K/AKT/GSK3β pathway in triple negative breast cancer [31] and blocked IL-8 mRNA expression in normal human epidermal keratinocytes [32]. The gene discussed is AKT1; the disease is triple-negative breast carcinoma.